{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:14:10Z","timestamp":1789370050062,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1023\/b:caco.0000027506.55846.5d","type":"journal-article","created":{"date-parts":[[2004,5,13]],"date-time":"2004-05-13T01:35:48Z","timestamp":1084412148000},"page":"419-428","source":"Crossref","is-referenced-by-count":119,"title":["Prior Medical Conditions and Medication use and Risk of non-Hodgkin lymphoma in Connecticut United States Women"],"prefix":"10.1007","volume":"15","author":[{"given":"Yawei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore R.","family":"Holford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Leaderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelia Hoar","family":"Zahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay McOmber","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia H.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongzhang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5270841_CR1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/1097-0142(19920815)70:4<840::AID-CNCR2820700420>3.0.CO;2-I","volume":"70","author":"T Zheng","year":"1992","unstructured":"Zheng T, Mayne ST, Boyle P, et al. (1992) Epidemiology of non-Hodgkin's lymphomas in Connecticut, 1935-1988. Cancer\n70: 840\u2013849.","journal-title":"Cancer"},{"issue":"20","key":"5270841_CR2","first-page":"423","volume":"19","author":"P Hartge","year":"1994","unstructured":"Hartge P, Devesa SS, Fraumeni Jr JF (1994) Hodgkin's and Non-Hodgkin's Lymphomas. Cancer Surv\n19\/20: 423\u2013453.","journal-title":"Cancer Surv"},{"key":"5270841_CR3","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(79)92942-8","volume":"1","author":"H Isomaki","year":"1979","unstructured":"Isomaki H, Hakulinen T, Joutsenlahti U (1979) Lymphoma and rheumatoid arthritis. Lancet\n1: 392\u2013\u00a6.","journal-title":"Lancet"},{"key":"5270841_CR4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jnci\/85.4.307","volume":"85","author":"G Gridley","year":"1993","unstructured":"Gridley G, McLaughlin JK, Ekbom A, et al. (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst\n85: 307\u2013311.","journal-title":"J Natl Cancer Inst"},{"key":"5270841_CR5","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/0959-8049(96)00210-9","volume":"32A","author":"L Mellemkjaer","year":"1996","unstructured":"Mellemkjaer L, Linet G, Gridley M, Frisch M, Moller H, Olsen JH (1996) Rheumatoid arthritis and cancer risk. Eur J Cancer\n32A: 1753\u20131757.","journal-title":"Eur J Cancer"},{"key":"5270841_CR6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/1097-0215(20001101)88:3<497::AID-IJC27>3.0.CO;2-J","volume":"88","author":"E Thomas","year":"2000","unstructured":"Thomas E, Brewster DH, Black R, Macfarlane GJ (2000) Risk of malignancy among patients with rheumatic conditions. Int J Cancer\n88: 497\u2013502.","journal-title":"Int J Cancer"},{"key":"5270841_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00008469-200002000-00008","volume":"9","author":"A Tavani","year":"2000","unstructured":"Tavani A, La Vecchia C, Franceschi S, Serraino D, Carbone A (2000) Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Eur J Cancer Prev\n9: 59\u201364.","journal-title":"Eur J Cancer Prev"},{"key":"5270841_CR8","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","volume":"89","author":"SS Kassan","year":"1978","unstructured":"Kassan SS, Thomas TL, Moutsopoulos HM, et al. (1978) Increased risk of lymphoma in sicca syndrome. Ann Int Med\n89: 888\u2013892.","journal-title":"Ann Int Med"},{"key":"5270841_CR9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0145-2126(84)90016-X","volume":"8","author":"SM Bernard","year":"1984","unstructured":"Bernard SM, Cartwright RA, Bird CC, Richards G, Lauder I, Roberts BE (1984) Aetiologic factors in lymphoid malignances: a case-control epidemiological study. Leuk Res\n8: 681\u2013689.","journal-title":"Leuk Res"},{"key":"5270841_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3109\/07357908509039813","volume":"3","author":"JD Cotelingam","year":"1985","unstructured":"Cotelingam JD, Witebsky FG, Hsu SM, Blaese RM, Jaffe ES (1985) Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Invest\n3: 515\u2013522.","journal-title":"Cancer Invest"},{"key":"5270841_CR11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0145-2126(98)80012-X","volume":"12","author":"RA Cartwright","year":"1988","unstructured":"Cartwright RA, McKinney PA, O'Brien C, et al. (1988) Non-Hodgkin's lymphoma: case control epidemiological study in Yorkshire. Leuk Res\n12: 81\u201388.","journal-title":"Leuk Res"},{"key":"5270841_CR12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF00051358","volume":"3","author":"MM Doody","year":"1992","unstructured":"Doody MM, Linet MS, Glass AG, et al. (1992) Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control\n3: 449\u2013456.","journal-title":"Cancer Causes Control"},{"key":"5270841_CR13","first-page":"5510s","volume":"52","author":"L Bernstein","year":"1992","unstructured":"Bernstein L, Ross RK (1992) Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles county. Cancer Res\n52: 5510s\u20135515s.","journal-title":"Cancer Res"},{"issue":"Suppl.1","key":"5270841_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1365-4362.36.s1.10.x","volume":"36","author":"F Arellano","year":"1997","unstructured":"Arellano F (1997) Risk of cancer with cyclosporine in psoriasis. Int J Dermatol\n36(Suppl. 1): 15\u201317.","journal-title":"Int J Dermatol"},{"key":"5270841_CR15","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1747.2000.00898.x","volume":"114","author":"A Hannuksela-Svahn","year":"2000","unstructured":"Hannuksela-Svahn A, Pukkala E, Laara E, Poikolainen K, Karvonen J (2000) Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol\n114: 587\u2013590.","journal-title":"J Invest Dermatol"},{"key":"5270841_CR16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0959-8049(02)00773-6","volume":"39","author":"MM Morales","year":"2003","unstructured":"Morales MM, Olsen J, Johansen P, et al. (2003) Viral infection, atopy and mycosis fungoides: a European multicentre case-control study. Eur J Cancer\n39: 511\u2013516.","journal-title":"Eur J Cancer"},{"key":"5270841_CR17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2133.1999.02655.x","volume":"140","author":"G Frentz","year":"1999","unstructured":"Frentz G, Olsen JH (1999) Malignant tumours and psoriasis: a follow-up study. Br J Dermatol\n140: 237\u2013242.","journal-title":"Br J Dermatol"},{"key":"5270841_CR18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1046\/j.0022-202x.2001.01520.x","volume":"117","author":"P Boffetta","year":"2001","unstructured":"Boffetta P, Gridley G, Lindelof B (2001) Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol\n117: 1531\u20131537.","journal-title":"J Invest Dermatol"},{"key":"5270841_CR19","first-page":"1466","volume":"11","author":"JR Cerhan","year":"2002","unstructured":"Cerhan JR, Vachon CM, Habermann TM, et al. (2002) Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomark Prev\n11: 1466\u20131471.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"5270841_CR20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jnci\/89.4.314","volume":"89","author":"JR Cerhan","year":"1997","unstructured":"Cerhan JR, Wallace RB, Folsom AR, et al. (1997) Medical history risk factors for non-Hodgkin's lymphoma in older women. J Natl Cancer Inst\n89: 314\u2013318.","journal-title":"J Natl Cancer Inst"},{"key":"5270841_CR21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/oxfordjournals.aje.a114087","volume":"122","author":"JE Vena","year":"1985","unstructured":"Vena JE, Bona JR, Byers TE, Middleton E, Swanson MK, Graham S (1985) Allergy-related diseases and cancer: an inverse association. Am J Epidemiol\n122: 66\u201374.","journal-title":"Am J Epidemiol"},{"key":"5270841_CR22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/1097-0142(19880715)62:2<451::AID-CNCR2820620234>3.0.CO;2-D","volume":"62","author":"WP McWhorter","year":"1988","unstructured":"McWhorter WP (1988) Allergy and risk of cancer. A prospective study using NHANESI followup data. Cancer\n62: 451\u2013455.","journal-title":"Cancer"},{"key":"5270841_CR23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1200\/JCO.2001.19.5.1381","volume":"19","author":"RA Nelson","year":"2001","unstructured":"Nelson RA, Levine AM, Bernstein L (2001) Reproductive factors and risk of intermediate-or high-grade B-cell non-Hodgkin's lymphoma. J Clin Oncol\n19: 1381\u20131387.","journal-title":"J Clin Oncol"},{"key":"5270841_CR24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/archneur.1970.00480230068008","volume":"22","author":"JJ Anthony","year":"1970","unstructured":"Anthony JJ (1970) Malignant lymphoma associated with hydantoin drugs. Arch Neurol\n22: 450\u2013454.","journal-title":"Arch Neurol"},{"key":"5270841_CR25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1097-0142(197510)36:4<1359::AID-CNCR2820360426>3.0.CO;2-L","volume":"36","author":"FP Li","year":"1975","unstructured":"Li FP, Willard DR, Goodman R, Vawter G (1975) Malignant lymphoma after diphenylhydantoin (dilantin) therapy. Cancer\n36: 1359\u20131362.","journal-title":"Cancer"},{"key":"5270841_CR26","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0140-6736(79)91505-8","volume":"2","author":"SJ White","year":"1979","unstructured":"White SJ, McLean AEM, Howland C (1979) Anticonvulsant drugs and cancer. A cohort study in patients with severe epilepsy. Lancet\n2: 458\u2013461.","journal-title":"Lancet"},{"key":"5270841_CR27","first-page":"83","volume":"77","author":"SB Shirts","year":"1986","unstructured":"Shirts SB, Annegers JF, Hauser WA, Kurland LT (1986) Cancer incidence in a cohort of patients with seizure disorders. J Natl Cancer Inst\n77: 83\u201387.","journal-title":"J Natl Cancer Inst"},{"key":"5270841_CR28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/81.10.803","volume":"81","author":"JH Olsen","year":"1989","unstructured":"Olsen JH, Boice JD, Jensen JPA, Fraumeni JF (1989) Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst\n81: 803\u2013808.","journal-title":"J Natl Cancer Inst"},{"key":"5270841_CR29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/oxfordjournals.aje.a117388","volume":"141","author":"L Rosenberg","year":"1995","unstructured":"Rosenberg L, Palmer JR, Zauber AG, et al. (1995) Relation of benzodiazepine use to the risk of selected cancers: breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkin's lymphoma, testis, Hodgkin's disease, thyroid, and liver. Am J Epidemiol\n141: 1153\u20131160.","journal-title":"Am J Epidemiol"},{"key":"5270841_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/oxfordjournals.epirev.a017980","volume":"20","author":"L Herrinton","year":"1998","unstructured":"Herrinton L (1998) Epidemiology of the Revised European-American Lymphoma classification subtypes. Epidemiol Rev\n20: 187\u2013203.","journal-title":"Epidemiol Rev"},{"key":"5270841_CR31","volume-title":"International Classification of Disease for Oncology","author":"World Health Organization","year":"1990","unstructured":"World Health Organization (1990) International Classification of Disease for Oncology, 2nd edn. Geneva, Switzerland: World Health Organization.","edition":"2nd edn."},{"key":"5270841_CR32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1018472213872","volume":"8","author":"M Kauppi","year":"1997","unstructured":"Kauppi M, Pukkala E, Isomaki H (1997) Elevated incidence of hematologic malignancies in patients with Sjogren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control\n8: 201\u2013204.","journal-title":"Cancer Causes Control"},{"key":"5270841_CR33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1136\/bmj.317.7152.180","volume":"317","author":"E Baecklund","year":"1998","unstructured":"Baecklund E, Ekbom A, Sparen P, Feltelius N, Klareskog L (1998) Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study. BMJ 317: 180\u2013181.","journal-title":"BMJ"},{"key":"5270841_CR34","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/1097-0142(19950901)76:5<910::AID-CNCR2820760528>3.0.CO;2-T","volume":"76","author":"AK Rosenthal","year":"1995","unstructured":"Rosenthal AK, McLaughlin JK, Gridley G, Nyren O (1995) Incidence of cancer among patients with systemic sclerosis. Cancer\n76: 910\u2013914.","journal-title":"Cancer"},{"key":"5270841_CR35","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2133.1995.tb08735.x","volume":"132","author":"U Amann","year":"1995","unstructured":"Amann U, Mielke V, Metze D, Bonsmann G, Schwarz T (1995) Perioral eczema as a manifestation of cutaneous T-cell lymphoma. Br J Dermatol\n132: 671\u2013673.","journal-title":"Br J Dermatol"},{"key":"5270841_CR36","first-page":"2809","volume":"59","author":"KB Elmer","year":"1999","unstructured":"Elmer KB, George RM (1999) Cutaneous T-cell lymphoma presenting as benign dermatoses. Am Fam Physician\n59: 2809\u20132813.","journal-title":"Am Fam Physician"},{"key":"5270841_CR37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0925-5710(95)00424-6","volume":"63","author":"T Sonoki","year":"1996","unstructured":"Sonoki T, Matsuzaki H, Asou N, et al. (1996) Aggressive CD5-positive di.use large B cell lymphoma showing c-myc rearrangements developed in a patient with autoimmune hemolytic anemia. Int J Hematol\n63: 71\u201376.","journal-title":"Int J Hematol"},{"key":"5270841_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s002770050341","volume":"75","author":"T Jameel","year":"1997","unstructured":"Jameel T, Anwar M, Abdi SI, Saleem M, Ahmad PA, Khattak MF (1997) Aplastic anemia or aplastic preleukemic syndrome? Ann Hematol\n75: 189\u2013193.","journal-title":"Ann Hematol"},{"key":"5270841_CR39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1023\/A:1025698109991","volume":"14","author":"AB Beiderbeck","year":"2003","unstructured":"Beiderbeck AB, Holly EA, Sturkenboom MC, Coebergh JW, Stricker BH, Leufkens HG (2003) No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands). Cancer Causes Control\n14: 639\u2013644.","journal-title":"Cancer Causes Control"},{"key":"5270841_CR40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1014354105164","volume":"13","author":"JR Cerhan","year":"2002","unstructured":"Cerhan JR, Habermann TM, Vachon CM, et al. (2002) Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa women's health study (United States). Cancer Causes Control\n13: 131\u2013136.","journal-title":"Cancer Causes Control"},{"key":"5270841_CR41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/(SICI)1097-0215(19970117)70:2<155::AID-IJC3>3.0.CO;2-W","volume":"70","author":"HO Adami","year":"1997","unstructured":"Adami HO, Tsaih S, Lambe M, et al. (1997) Pregnancy and risk of non-Hodgkin's lymphoma: a prospective study [erratum appears in Int J Cancer 1997 May 16; 71(4): 705]. Int J Cancer\n70: 155\u2013158.","journal-title":"Int J Cancer"},{"key":"5270841_CR42","unstructured":"Zheng T, Zhang Y, Morton L, Zhu Y (in press) Re: No increased risk of non-Hodgkin's lymphoma with steroids, estrogens and psychotropics (Netherlands) Cancer Causes Control."},{"key":"5270841_CR43","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1126\/science.1621100","volume":"257","author":"RL Jilka","year":"1992","unstructured":"Jilka RL, Hangoc G, Girasole G, et al. (1992) Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science\n257: 88\u201391.","journal-title":"Science"},{"key":"5270841_CR44","first-page":"2043","volume":"83","author":"D Cheleuitte","year":"1998","unstructured":"Cheleuitte D, Mizuno S, Glowacki J (1998) in vitro secretion of cytokines by human bone marrow: Effects of age and estrogen status. J Clin Endocrinol Metab\n83: 2043\u20132051.","journal-title":"J Clin Endocrinol Metab"},{"key":"5270841_CR45","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI115668","volume":"89","author":"G Girasole","year":"1992","unstructured":"Girasole G, Jilka RL, Passeri G, et al. (1992) 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest\n89: 883\u2013891.","journal-title":"J Clin Invest"},{"key":"5270841_CR46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000053005","volume":"53","author":"R Saucedo","year":"2002","unstructured":"Saucedo R, Rico G, Basurto L, Ochoa R, Zarate A (2002) Transdermal estradiol in menopausal women depresses interleukin-6 without affecting other markers of immune response. Gynecol Obstetric Invest\n53: 114\u2013117.","journal-title":"Gynecol Obstetric Invest"},{"key":"5270841_CR47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1677\/joe.0.1720387","volume":"172","author":"D Rachon","year":"2002","unstructured":"Rachon D, MySliwska J, Suchecka-Rachon K, Wieckiewicz J, MySliwski A (2002) Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women. J Endocrinol\n172: 387\u2013395.","journal-title":"J Endocrinol"},{"key":"5270841_CR48","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S8756-3282(01)00468-9","volume":"29","author":"A Rogers","year":"2001","unstructured":"Rogers A, Eastell R (2001) The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood. Bone\n29: 30\u201334.","journal-title":"Bone"},{"key":"5270841_CR49","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.4049\/jimmunol.142.9.3134","volume":"142","author":"SS Tabibzadeh","year":"1989","unstructured":"Tabibzadeh SS, Santhanam U, Sehgal PB, May LT (1989) Cytokine-induced production of IFN-beta 2\/IL-6 by freshly explanted human endometrial stromal cells. Modulation by estradiol-17 beta. J Immunol\n142: 3134\u20133139.","journal-title":"J Immunol"},{"key":"5270841_CR50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-127-3-199708010-00002","volume":"127","author":"HA Preti","year":"1997","unstructured":"Preti HA, Cabanillas F, Talpaz M, Tucker SL, Seymour JF, Kurzrock R (1997) Prognostic value of serum interleukin-6 in diffuse large-cell lymphoma [comment]. Ann Intern Med\n127: 186\u2013194.","journal-title":"Ann Intern Med"},{"key":"5270841_CR51","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00001648-199603000-00005","volume":"7","author":"MM Doody","year":"1996","unstructured":"Doody MM, Linet MS, Glass AG, et al. (1996) Risks of non-Hodgkin's lymphoma, multiple myeloma, and Leukemia associated with common medications. Epidemiology\n7: 131\u2013139.","journal-title":"Epidemiology"},{"key":"5270841_CR52","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1023\/A:1021953224822","volume":"13","author":"I Kato","year":"2002","unstructured":"Kato I, Koenig KL, Shore RE, et al. (2002) Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States). Cancer Causes Control\n13: 965\u2013974.","journal-title":"Cancer Causes Control"},{"key":"5270841_CR53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/oxfordjournals.aje.a010017","volume":"150","author":"EA Holly","year":"1999","unstructured":"Holly EA, Lele C, Bracci PM, McGrath MS (1999) Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California.\nAm J Epidemiol\n150: 375\u2013389.","journal-title":"Am J Epidemiol"},{"key":"5270841_CR54","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/ijc.11311","volume":"106","author":"JR Cerhan","year":"2003","unstructured":"Cerhan JR, Anderson KE, Janney CA, Vachon CM, Witzig TE, Habermann TM (2003) Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int J Cancer\n106: 784\u2013788.","journal-title":"Int J Cancer"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CACO.0000027506.55846.5d.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:CACO.0000027506.55846.5d\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CACO.0000027506.55846.5d.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:57:35Z","timestamp":1750960655000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:CACO.0000027506.55846.5d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["5270841"],"URL":"https:\/\/doi.org\/10.1023\/b:caco.0000027506.55846.5d","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}